journal article·2023-03-29Open access

Development of a COX-2-Selective Fluorescent Probe for the Observation of Early Intervertebral Disc Degeneration

Cheol Ho Heo, Eun Ji Roh, Jaehee Kim, Hyemin Choi, Ho Yeon Jang, Giseong Lee, Chang Su Lim, Inbo Han

Abstract

Cyclooxygenase-2 (COX-2) is a biomolecule known to be overexpressed in inflammation. Therefore, it has been considered a diagnostically useful marker in numerous studies. In this study, we attempted to assess the correlation between COX-2 expression and the severity of intervertebral disc (IVD) degeneration using a COX-2-targeting fluorescent molecular compound that had not been extensively studied. This compound, indomethacin-adopted benzothiazole-pyranocarbazole (IBPC1), was synthesized by introducing indomethacin—a compound with known selectivity for COX-2—into a phosphor with a benzothiazole-pyranocarbazole structure. IBPC1 exhibited relatively high fluorescence intensity in cells pretreated with lipopolysaccharide, which induces inflammation. Furthermore, we observed significantly higher fluorescence in tissues with artificially damaged discs (modeling IVD degeneration) compared to normal disc tissues. These findings indicate that IBPC1 can meaningfully contribute to the study of the mechanism of IVD degeneration in living cells and tissues and to the development of therapeutic agents.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Spine and Intervertebral Disc Pathology · Inflammatory mediators and NSAID effects · Anesthesia and Pain Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea

Pure Chem Co., Ltd., Knu Start-up CUBE, Chunchenon 24341, Republic of Korea

Department of Neurosurgery, CHA University School of Medicine, CHA Bundang Medical Center, Seongnam-si 13496, Republic of Korea

Department of Biomedical Science, CHA University School of Medicine, CHA Bundang Medical Center, Seongnam-si 13496, Republic of Korea

College of General Education, Kookmin University, Seoul 02707, Republic of Korea

Funding

Korea Healthcare Technology Research & Development Project, Ministry of Health and Welfare, Republic of Korea · National Research Foundation of Korea (NRF) · R&BD Program through the INNOPOLIS funded by Ministry of Science and ICT

References (37)

Show source-provided references
1. Extra Cellular Matrix Remodeling: An Adjunctive Target for Spinal Cord Injury and Intervertebral Disc Degeneration10.14245/ns.2244366.183 ↗
2. Painful intervertebral disc degeneration and inflammation: From laboratory evidence to clinical interventions10.1038/s41413-020-00125-x ↗
3. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: A systematic analysis for the Global Burden of Disease Study 201910.1016/S0140-6736(20)32340-0 ↗
4. Moving Forward: Gene Therapy for Intervertebral Disc Degeneration10.14245/ns.2040108.054 ↗
5. Intervertebral Disc Degeneration: Biomaterials and Tissue Engineering Strategies toward Precision Medicine10.1002/adhm.202102530 ↗
6. Roh, E.J., Darai, A., Kyung, J., Choi, H., Kwon, S., Bhujel, B., Kim, K., and Han, I. (2021). Genetic therapy for intervertebral disc degeneration. Int. J. Mol. Sci., 22.10.3390/ijms22041579 ↗
7. Degeneration of the intervertebral disc10.1186/ar629 ↗
8. A Brief Review of the Degenerative Intervertebral Disc Disease10.5455/medarh.2019.73.421-424 ↗
9. The role of structure and function changes of sensory nervous system in intervertebral disc-related low back pain10.1016/j.joca.2020.09.002 ↗
10. The Beneficial Effect of Early Surgical Decompression for Acute Spinal Cord Injury: Time Is Spine10.14245/ns.2142256.128 ↗
11. A Comparison of Mortality and Morbidity between Complex and Degenerative Spine Surgery in Prospectively Collected Data from 2280 Procedures10.14245/ns.2040628.314 ↗
12. Diagnostic testing for degenerative disc disease10.1155/2012/413913 ↗
13. Cyclooxygenase in normal human tissues—Is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?10.1111/j.1582-4934.2008.00430.x ↗
14. Actions of Prostaglandins on Human Nucleus Pulposus Metabolism Inferred by Cyclooxygenase 2 Inhibition of Cytokine Activated Cells10.14245/ns.2040050.025 ↗
15. Cyclooxygenase-2 deficiency causes delayed ossification of lumbar vertebral endplates
16. The Upregulation of COX2 in Human Degenerated Nucleus Pulposus: The Association of Inflammation with Intervertebral Disc Degeneration10.1155/2021/2933199 ↗
17. Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei10.1002/cyto.10026 ↗
18. Cyclooxygenase-2 is critical for the propagation of beta-amyloid protein and reducing the glycosylation of tau in Alzheimer’s disease10.1038/s41423-019-0294-1 ↗
19. Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype10.1038/s41598-017-09528-z ↗
20. Inhibition of cyclooxygenase-2 by NS398 attenuates noise-induced hearing loss in mice10.1038/srep22573 ↗
21. Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis10.1038/s41413-019-0071-x ↗
22. Follistatin-like 1 attenuation suppresses intervertebral disc degeneration in mice through interacting with TNF-α and Smad signaling pathway10.1155/2021/6640751 ↗
23. New and efficient routes for the synthesis of murrayaquinone A and murrayanine10.1016/j.tet.2012.05.127 ↗
24. Measurement of photoluminescence quantum yields. Review10.1021/j100678a001 ↗
25. Choi, U.Y., Joshi, H.P., Payne, S., Kim, K.T., Kyung, J.W., Choi, H., Cooke, M.J., Kwon, S.Y., Roh, E.J., and Sohn, S. (2020). An Injectable Hyaluronan-Methylcellulose (HAMC) Hydrogel Combined with Wharton’s Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair. Int. J. Mol. Sci., 21.10.3390/ijms21197391 ↗
26. A selective inhibition of c-Fos/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain10.1038/s41598-017-17289-y ↗
27. Quantitative MRI correlates with histological grade in a percutaneous needle injury mouse model of disc degeneration10.1002/jor.24028 ↗
28. An off–on Cox-2-specific fluorescent probe: Targeting the golgi apparatus of cancer cells10.1021/ja4056905 ↗
29. Highly sensitive naphthalene-based two-photon fluorescent probe for in situ real-time bioimaging of ultratrace cyclooxygenase-2 in living biosystems10.1021/ac501944y ↗
30. A Nile blue based infrared fluorescent probe: Imaging tumors that over-express cyclooxygenase-210.1039/C4CC08915D ↗
31. COX-2 targeting indomethacin conjugated fluorescent probe10.1016/j.dyepig.2017.11.053 ↗
32. Development of two-photon fluorescence probe for detecting cyclooxygenase-2 level in human colorectal cancer tissue10.1016/j.snb.2020.129329 ↗
33. Discovery of a redox-activatable chemical probe for detection of cyclooxygenase-2 in cells and animals10.1021/acschembio.1c00961 ↗
34. Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors10.1073/pnas.97.2.925 ↗
35. The 2′-trifluoromethyl analogue of indomethacin is a potent and selective COX-2 inhibitor10.1021/ml400066a ↗
36. Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations10.1038/s41467-022-29606-9 ↗
37. The inflammatory response in the regression of lumbar disc herniation10.1186/s13075-018-1743-4 ↗